Trial Profile

A First in Human Study to Evaluate the Glucose-Responsive Insulin

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 08 Feb 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin (Primary)
Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
Focus Adverse reactions; First in man
Sponsors Sensulin

Most Recent Events

08 Feb 2019 New trial record
23 May 2018 According to an AngelMD media release, a group of physician and investor members of the company has completed the latest funding round for Sensulin, LLC.Sensulin will use the funds to push forward its research and development and conduct this first in human study for the glucose-responsive insulin.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com